Patel DN - Search Results

1

Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.

Patel DN, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen ZW, Terris MK, Freedland SJ. Patel DN, et al. Cancer. 2020 Jul 15;126(14):3274-3280. doi: 10.1002/cncr.32933. Epub 2020 May 6. Cancer. 2020. PMID: 32374476 Free article.

2

New Prostate Cancer Biomarkers: The Search Continues.

Patel DN, Freedland SJ. Patel DN, et al. Eur Urol. 2017 Dec;72(6):950-951. doi: 10.1016/j.eururo.2017.04.013. Epub 2017 Apr 24. Eur Urol. 2017. PMID: 28450184 No abstract available.

3

PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.

Patel DN, Feng T, Simon RM, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Roehrborn C, Andriole GL, Freedland SJ. Patel DN, et al. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):238-244. doi: 10.1038/s41391-018-0044-y. Epub 2018 May 23. Prostate Cancer Prostatic Dis. 2018. PMID: 29795141 Clinical Trial.

4

Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.

Patel DN, Jha S, Howard LE, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Chapin BF, Freedland SJ. Patel DN, et al. Int J Urol. 2018 Dec;25(12):998-1004. doi: 10.1111/iju.13806. Epub 2018 Sep 25. Int J Urol. 2018. PMID: 30253446 Free PMC article.

5

Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.

Patel DN, Chapin BF, Freedland SJ. Patel DN, et al. Int J Urol. 2018 Dec;25(12):1005. doi: 10.1111/iju.13861. Epub 2018 Nov 20. Int J Urol. 2018. PMID: 30458585 No abstract available.

6

Neoadjuvant Approaches Prior To Radical Prostatectomy.

Ryan ST, Patel DN, Parsons JK, McKay RR. Ryan ST, et al. Among authors: patel dn. Cancer J. 2020 Jan/Feb;26(1):2-12. doi: 10.1097/PPO.0000000000000424. Cancer J. 2020. PMID: 31977379 Review.

7

Public interest in dietary supplements for prostate cancer prevention.

Patel DN, Kuhlmann P, Lin PH, Freedland SJ. Patel DN, et al. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):58-60. doi: 10.1038/s41391-020-0257-8. Epub 2020 Jul 19. Prostate Cancer Prostatic Dis. 2021. PMID: 32684622 Review. No abstract available.

8

Patient- and tumor-level risk factors for MRI-invisible prostate cancer.

Kuhlmann PK, Chen M, Luu M, Naser-Tavakolian A, Patel DN, Kim HL, Saouaf R, Daskivich TJ. Kuhlmann PK, et al. Among authors: patel dn. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):794-801. doi: 10.1038/s41391-021-00330-7. Epub 2021 Feb 10. Prostate Cancer Prostatic Dis. 2021. PMID: 33568751

9

Next-generation imaging in localized high-risk prostate cancer.

Patel DN, Karsh LI, Daskivich TJ. Patel DN, et al. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):585-586. doi: 10.1038/s41391-021-00356-x. Epub 2021 Mar 31. Prostate Cancer Prostatic Dis. 2021. PMID: 33790419 No abstract available.

10

Correction: Public interest in dietary supplements for prostate cancer prevention.

Patel DN, Kuhlmann P, Lin PH, Freedland SJ. Patel DN, et al. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):376. doi: 10.1038/s41391-021-00410-8. Prostate Cancer Prostatic Dis. 2022. PMID: 34145429 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page